Entering text into the input field will update the search result below

RTI Biologics (RTIX -13.5%) trades down into the close despite beating Q4 estimates. Profit...

Jan. 31, 2012 4:05 PM ETSurgalign Holdings, Inc. (SRGAQ) StockSRGAQBy: David Yelle, SA News Editor
RTI Biologics (RTIX -13.5%) trades down into the close despite beating Q4 estimates. Profit actually declined 5.5% Y/Y due to inventory issues, which masked a 20% jump in international sales. The company warns on FY12 guidance however, now saying it expects revenue in the range of $174M - $176M. Analysts are looking for sales of $176M.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
SRGAQ--
Surgalign Holdings, Inc.